HCP, Inc.  

(Public, NYSE:HCP)   Watch this stock  
Find more results for hcp
+0.09 (0.29%)
Feb 17 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 30.75 - 31.11
52 week 27.61 - 40.43
Open 30.97
Vol / Avg. 2.22M/4.46M
Mkt cap 14.59B
P/E 40.25
Div/yield 0.37/4.76
EPS 0.77
Shares 468.18M
Beta 0.22
Inst. own 97%
Feb 7, 2017
Q4 2016 HCP Inc Earnings Release (Estimated)
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin -127.64% 17.04%
Operating margin -118.83% 31.15%
EBITD margin - 60.46%
Return on average assets -4.77% 1.95%
Return on average equity -11.29% 4.85%
Employees 188 -
CDP Score - 98 A minus


1920 Main St Ste 1200
IRVINE, CA 92614-7230
United States - Map
+1-949-4070700 (Phone)
+1-562-7335200 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


HCP, Inc. (HCP) is a self-administered real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital. Its portfolio includes owned portfolio, unconsolidated joint ventures, and developments and redevelopments. It has interests in unconsolidated joint ventures representing approximately 30 properties primarily in its senior housing, life science and medical office segments. The Company has interests in approximately 530 senior housing facilities, including over 25 properties owned by its unconsolidated joint ventures. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes and continuing care retirement communities. It has interests in approximately 310 post-acute/skilled nursing facilities.

Officers and directors

Michael Dale McKee Executive Chairman of the Board
Age: 70
Bio & Compensation  - Reuters
J. Justin Hutchens President
Age: 42
Bio & Compensation  - Reuters
Thomas M. Herzog Chief Executive Officer, Director
Age: 54
Bio & Compensation  - Reuters
Peter Scott Chief Financial Officer, Executive Vice President
Age: 37
Bio & Compensation  - Reuters
Scott A. Anderson Executive Vice President, Chief Accounting Officer
Age: 54
Bio & Compensation  - Reuters
Troy E. McHenry Executive Vice President, General Counsel, Corporate Secretary
Age: 43
Bio & Compensation  - Reuters
Jonathan M. Bergschneider Executive Vice President - Life Science Estates
Age: 41
Bio & Compensation  - Reuters
Thomas D. Kirby Executive Vice President - Acquisitions and Valuations
Age: 69
Bio & Compensation  - Reuters
Thomas M. Klaritch CPA Executive Vice President - Medical Office Properties
Age: 58
Bio & Compensation  - Reuters
Darren A. Kowalske Executive Vice President - Asset Management, Senior Housing and Care
Age: 55
Bio & Compensation  - Reuters